Anavex Screening Healthy Volunteers for Phase I, First-in-Human Clinical Study in Alzheimer’s disease March 31, 2011
Anavex Comments on President Obama’s Signing of National Alzheimer’s Project Act into Law January 18, 2011
Alzheimer’s Weekly Names ANAVEX 2-73 the Number One Most Promising Trial Drug in Alzheimer’s Disease and Anavex’s Phase I Clinical Program as “Trial of the Year” January 6, 2011
